San Francisco Sentry Investment Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-550
Closed -$13K – 893
2018
Q2
$13K Sell
550
-5,750
-91% -$119K 0.01% 546
2018
Q1
$100K Hold
6,300
– – 0.03% 366
2017
Q4
$131K Buy
6,300
+1,900
+43% +$30.1K 0.04% 321
2017
Q3
$63K Buy
4,400
+400
+10% +$6.05K 0.02% 391
2017
Q2
$69K Buy
+4,000
New +$47.9K 0.02% 325
2014
Q4
– Sell
-350
Closed -$46K – 185
2014
Q3
$46K Hold
350
– – 0.02% 307
2014
Q2
$44K Hold
350
– – 0.02% 329
2014
Q1
$46K Buy
+350
New +$47.9K 0.01% 365

Other funds holding BHC

San Francisco Sentry Investment Group's BHC Position: Q3 2018 in Review

San Francisco Sentry Investment Group sold out of Bausch Health (BHC) in Q3 2018, closing a stake of 550 shares — an estimated $13K sold.

San Francisco Sentry Investment Group first reported a position in BHC in Q1 2014 and held it in 8 quarters. The position peaked at $131K in Q4 2017. 332 funds tracked by Wall St. Rank hold BHC as of Q3 2018.

  • San Francisco Sentry Investment Group reported no remaining Bausch Health position as of Q3 2018 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 550 Bausch Health shares in Q3 2018, an estimated $13K.
  • San Francisco Sentry Investment Group first reported a position in Bausch Health in Q1 2014 and held it in 8 quarters.
  • San Francisco Sentry Investment Group's Bausch Health position peaked at $131K in Q4 2017.
  • 332 funds tracked by Wall St. Rank held Bausch Health as of Q3 2018.

Based on San Francisco Sentry Investment Group's 13F filing for Q3 2018, filed 9 Nov 2018.